Methadone Market Share

  • Report ID: 3793
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Methadone Market Share

North American Market Forecast

 North America industry is likely to account for largest revenue share of 42% by 2037, driven by increasing cases of drug addiction in the region.. According to the Centre for Disease Control and Prevalence (CDC) in 2019, 70,630 deaths were caused by drug overdose in the United States. Additionally, the increased prevalence of misery and the increase in substance abuse cases, have further fueled regional expansion. High distress is also associated with an increase in the number of patients using methadone to treat persistent post-operative pain.

APAC Market Statistics

On the other, the market in the Asia-Pacific region is expected to have significant growth in the forecast period. This is owing to the fact that India and China are countries that have high populations, especially geriatric ones. This indicates that people in these countries have chances to get affected by chronic diseases which in turn will drive the growth of the market in the upcoming time.

Europe Market Forecast

The market in the Europe region is estimated to have steady growth in the forecast period. This is ascribed owing to the high obtainment of analgesics. Factors such as the high population suffering from chronic and respiratory diseases in this region are driving the growth of this market in the European region. As discussed in the previous part that methadone helps to treat quite a lot of chronic diseases as well as gives relief to deadly pain the body is suffering from.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3793
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of methadone is evaluated at USD 193.93 million.

The methadone market size was over USD 172.86 million in 2024 and is poised to exceed USD 437.27 million by 2037, witnessing over 7.4% CAGR during the forecast period i.e., between 2025-2037. The growing demand for methadone rehabilitation of heroin addicts will drive the market growth.

North America industry is likely to account for largest revenue share of 42% by 2037, driven by increasing cases of drug addiction in the region.

The major players in the market are Eli Lilly and Company, Sanofi S.A., Hikma Labs Inc., Mallinckrodt Pharmaceuticals, Siegfried Holding AG, Johnson Matthey, Gilead Sciences, Inc., BioControl Medical, Tianjin Central Pharmaceutical Industry Co., Ltd.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample